• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症与肾脏:危险的关联还是医学进步所付出的代价?

Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?

作者信息

Małyszko Jolanta, Kozlowski Leszek, Kozłowska Klaudia, Małyszko Maciej, Małyszko Jacek

机构信息

Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.

Department of Oncological Surgery, Ministry of Interior Affairs, Bialystok, Poland.

出版信息

Oncotarget. 2017 May 23;8(39):66601-66619. doi: 10.18632/oncotarget.18094. eCollection 2017 Sep 12.

DOI:10.18632/oncotarget.18094
PMID:29029541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5630441/
Abstract

A long time ago, the links between renal disease and malignancy were observed, however, quite recently, their importance was recognized and 'new' subspecialty in nephrology, namely 'onconephrology' was established. In the XXI century, patients with malignancy make up the most growing number of the subjects seen for nephrology consult and/or critical care nephrology services. A plethora of renal problems may be found in patients with malignancy. They may influence not only their short-term outcomes but also the adequate therapy of the underlying oncological problem. Thus, all these kidney-related issues pose an important challenge for both specialities: oncology and nephrology. In the review a spectrum of acute and chronic renal injury caused by the malignancy is presented as well as the associations between renal disease and cancer. Assessment of kidney function and its importance in patients with malignancy is also discussed as medical oncologists should check the appropriate dose of chemotherapeutic drugs in relation to the actual renal function before prescribing them to the patients. Moreover, effects of kidney function on outcomes in oncology is presented. In addition, nephrology services should better understand both the biology of malignancy with its treatment to become a valuable part treating team to yield the best possible outcome. It is important for nephrology services to be acknowledged and to take an active participation in care of oncology patients.

摘要

很久以前,人们就观察到肾脏疾病与恶性肿瘤之间的联系,然而,直到最近,它们的重要性才得到认可,肾脏病学领域出现了一个“新”的亚专业,即“肿瘤肾脏病学”。在21世纪,患有恶性肿瘤的患者是肾脏病咨询和/或重症监护肾脏病服务中数量增长最多的就诊对象。恶性肿瘤患者可能会出现大量肾脏问题。这些问题不仅可能影响他们的短期预后,还会影响潜在肿瘤问题的适当治疗。因此,所有这些与肾脏相关的问题对肿瘤学和肾脏病学这两个专业都构成了重大挑战。本综述介绍了由恶性肿瘤引起的一系列急性和慢性肾损伤,以及肾脏疾病与癌症之间的关联。还讨论了恶性肿瘤患者肾功能评估及其重要性,因为肿瘤内科医生在给患者开化疗药物之前,应根据实际肾功能检查化疗药物的合适剂量。此外,还介绍了肾功能对肿瘤学预后的影响。此外,肾脏病服务机构应更好地了解恶性肿瘤的生物学特性及其治疗方法,以便成为治疗团队中有价值的一部分,从而取得尽可能好的治疗效果。肾脏病服务机构得到认可并积极参与肿瘤患者的护理非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd57/5630441/77739ffe03e8/oncotarget-08-66601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd57/5630441/ce3f8e59ab07/oncotarget-08-66601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd57/5630441/77739ffe03e8/oncotarget-08-66601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd57/5630441/ce3f8e59ab07/oncotarget-08-66601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd57/5630441/77739ffe03e8/oncotarget-08-66601-g002.jpg

相似文献

1
Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?癌症与肾脏:危险的关联还是医学进步所付出的代价?
Oncotarget. 2017 May 23;8(39):66601-66619. doi: 10.18632/oncotarget.18094. eCollection 2017 Sep 12.
2
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.儿科肿瘤肾脏病学:传播信息的时刻-第二部分:儿童期恶性肿瘤幸存者和肾移植后恶性肿瘤的长期肾脏结局。
Pediatr Nephrol. 2022 Jun;37(6):1285-1300. doi: 10.1007/s00467-021-05172-y. Epub 2021 Sep 6.
3
Onconephrology: The intersections between the kidney and cancer.肿瘤肾脏病学:肾脏与癌症的交集。
CA Cancer J Clin. 2021 Jan;71(1):47-77. doi: 10.3322/caac.21636. Epub 2020 Aug 27.
4
[Ten Years of Onconephrology].[肿瘤肾脏病学十年]
G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
5
Onconephrology: mitigation of renal injury in chemotherapy administration.肿瘤肾脏病学:减轻化疗药物治疗中的肾损伤。
Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):257-266. doi: 10.1097/MNH.0000000000000960. Epub 2023 Dec 14.
6
Onconephrology abstracts and publication trends: time to collaborate.肿瘤肾脏病学摘要与出版趋势:是时候开展合作了。
Clin Kidney J. 2015 Oct;8(5):629-31. doi: 10.1093/ckj/sfv085. Epub 2015 Sep 24.
7
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.KDIGO肿瘤肾脏病学争议会议:了解肾功能损害与实体器官恶性肿瘤,以及肾癌的管理
Kidney Int. 2020 Nov;98(5):1108-1119. doi: 10.1016/j.kint.2020.06.046.
8
Onco-Nephrology in the Critical Care Setting: Recognizing and Treating Renal Manifestations of Cancer and Oncological Emergencies.危重症中的肿瘤肾脏病学:认识和治疗癌症及肿瘤急症的肾脏表现。
Crit Care Nurs Clin North Am. 2022 Dec;34(4):453-466. doi: 10.1016/j.cnc.2022.07.002. Epub 2022 Oct 13.
9
The basics of onco-nephrology in the renal clinic.肾脏科临床中的肿瘤肾脏病学基础
J Nephrol. 2020 Dec;33(6):1143-1149. doi: 10.1007/s40620-020-00922-x.
10
Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.小儿肿瘤肾脏病学:是时候广而告之了:第一部分:恶性肿瘤患儿的早期肾脏受累情况
Pediatr Nephrol. 2021 Aug;36(8):2227-2255. doi: 10.1007/s00467-020-04800-3. Epub 2020 Nov 27.

引用本文的文献

1
A randomized controlled trial comparing pioglitazone and metformin prior to in vitro fertilization in polycystic ovary syndrome - associated infertile women: impact on pregnancy rates.一项在多囊卵巢综合征相关不孕女性体外受精前比较吡格列酮和二甲双胍的随机对照试验:对妊娠率的影响。
Ann Med Surg (Lond). 2024 Feb 28;86(5):2696-2701. doi: 10.1097/MS9.0000000000001816. eCollection 2024 May.
2
Cancer before and after the start of hemodialysis and association with mortality - an Eastern-European multicenter study.开始血液透析前后的癌症及与死亡率的关系-一项东欧多中心研究。
Ren Fail. 2023 Dec;45(1):2232046. doi: 10.1080/0886022X.2023.2232046.
3

本文引用的文献

1
Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient.肾移植等待名单上的合并症与潜在受者的状况相关。
Arch Med Sci. 2018 Jun;14(4):941-944. doi: 10.5114/aoms.2016.60337. Epub 2016 Jun 1.
2
Nephrotoxicity of anticancer treatment.抗肿瘤治疗的肾毒性。
Nephrol Dial Transplant. 2017 Jun 1;32(6):924-936. doi: 10.1093/ndt/gfw338.
3
Adverse kidney effects of epidermal growth factor receptor inhibitors.表皮生长因子受体抑制剂的肾脏不良效应。
Machine learning for acute kidney injury: Changing the traditional disease prediction mode.
用于急性肾损伤的机器学习:改变传统疾病预测模式。
Front Med (Lausanne). 2023 Feb 3;10:1050255. doi: 10.3389/fmed.2023.1050255. eCollection 2023.
4
Risk of malignancy in patients with chronic kidney disease.慢性肾脏病患者的恶性肿瘤风险。
PLoS One. 2022 Aug 17;17(8):e0272910. doi: 10.1371/journal.pone.0272910. eCollection 2022.
5
Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.与化疗诱导的 AKI 相关的分子机制和生物标志物。
Int J Mol Sci. 2022 Feb 27;23(5):2638. doi: 10.3390/ijms23052638.
6
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.托伐普坦对环磷酰胺诱导的大鼠模型肾毒性的保护作用。
Pharmacol Res Perspect. 2020 Oct;8(5):e00659. doi: 10.1002/prp2.659.
7
Prediction models for acute kidney injury in patients with gastrointestinal cancers: a real-world study based on Bayesian networks.基于贝叶斯网络的胃肠道癌患者急性肾损伤预测模型:一项真实世界研究。
Ren Fail. 2020 Nov;42(1):869-876. doi: 10.1080/0886022X.2020.1810068.
8
Immune Dysfunction in Uremia 2020.尿毒症中的免疫功能障碍 2020 年
Toxins (Basel). 2020 Jul 5;12(7):439. doi: 10.3390/toxins12070439.
9
Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities.为什么肾功能损害与乳腺癌患者的癌症特异性生存率较差相关?:与其他合并症患者的比较。
Int J Clin Oncol. 2020 Oct;25(10):1786-1792. doi: 10.1007/s10147-020-01733-7. Epub 2020 Jul 2.
10
Adhesion GPCRs in Kidney Development and Disease.黏附性G蛋白偶联受体在肾脏发育与疾病中的作用
Front Cell Dev Biol. 2018 Feb 6;6:9. doi: 10.3389/fcell.2018.00009. eCollection 2018.
Nephrol Dial Transplant. 2017 Jul 1;32(7):1089-1097. doi: 10.1093/ndt/gfw467.
4
Renal effects of immune checkpoint inhibitors.免疫检查点抑制剂的肾脏作用。
Nephrol Dial Transplant. 2017 Jun 1;32(6):936-942. doi: 10.1093/ndt/gfw382.
5
Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie.癌症患者慢性肾脏替代治疗的发生率和特征:来自下诺曼底地区肾脏和癌症登记处的数据。
J Nephrol. 2018 Feb;31(1):111-118. doi: 10.1007/s40620-016-0356-8. Epub 2016 Nov 4.
6
Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines.实体器官移植受者的癌症筛查建议:临床实践指南的系统评价
Am J Transplant. 2017 Jan;17(1):103-114. doi: 10.1111/ajt.13978. Epub 2016 Aug 30.
7
Checkmate: kidney injury associated with targeted cancer immunotherapy.Checkmate:与靶向癌症免疫疗法相关的肾损伤。
Kidney Int. 2016 Sep;90(3):474-6. doi: 10.1016/j.kint.2016.05.024.
8
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的急性肾损伤的临床病理特征
Kidney Int. 2016 Sep;90(3):638-47. doi: 10.1016/j.kint.2016.04.008. Epub 2016 Jun 7.
9
Renal Function and All-Cause Mortality Risk Among Cancer Patients.癌症患者的肾功能与全因死亡风险
Medicine (Baltimore). 2016 May;95(20):e3728. doi: 10.1097/MD.0000000000003728.
10
Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.肺癌患者程序性细胞死亡蛋白 1 抑制剂治疗与急性间质性肾炎的相关性。
Am J Kidney Dis. 2016 Aug;68(2):287-291. doi: 10.1053/j.ajkd.2016.02.057. Epub 2016 Apr 22.